Guidance for Industry
...also require appropriate retesting of any component, drug product container, or closure that is subject.....In an aseptic process, the drug product, container, and closure are first subjected to.....terminally sterilized drug product, on the other hand, undergoes a single sterilization process..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=100)

Guidance for Industry
...also require appropriate retesting of any component, drug product container, or closure that is subject.....In an aseptic process, the drug product, container, and closure are first subjected to.....terminally sterilized drug product, on the other hand, undergoes a single sterilization process..
http://www.fda.gov/cder/guidance/1874dft.pdf (score=94)

Guidance for Industry
...ensuring that the drug product provided to the patient has the appropriate identity, strength.....oxygen container, installed it on the argon container, and connected the deadly product to.....if the condition of the drug product, as a result of storage or shipping, casts doubt on the..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03d-0165-gdl0001.pdf (score=89)

Sterile Drug Products Produced by Aseptic Processing
...In an aseptic process, the drug product, container, and closure are first subjected to sterilization.....The sterile drug product and its container-closures should be protected by equipment of.....Drug product containers and closures shall be clean and, where indicated by the nature of the..
http://www.fda.gov/cder/guidance/5882fnl.htm (score=82)

Guidance on the Packaging of Test Batches
...table of packaging information describing the container/closure system,the total number of.....For liquids, the total amount of bulk product packaged should be,at a minimum, 10 percent.....validation studies are conducted prior to the marketing of a drug product to assure..that..
http://www.fda.gov/cder/mapp/5225-1.pdf (score=73)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....made to verify that the correct label has been affixed to the container and the shield.....or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=64)

Fresh Air '2000' A look at FDA's Medical Gas Requirements
...Finally, a finished drug product odor test must be performed on each container undergoing.....Drug product containers and closures play a critical role in assuring that the drug product.....This would pertain to any container or closure used to deliver industrial products, any..
http://www.fda.gov/cder/dmpq/freshair.htm (score=61)

/a//content.14388
...Mixing, granulating, milling, molding, of components, drug product containers, formulating.....Therefore, under the Federal Food, all established standards, specifications, Drug, and.....drug product container, or closure, the.. require examination of the component.. validation provisions..
http://www.fda.gov/cder/dmpq/fr5396.pdf (score=61)

HUMAN DRUG CGMP NOTES, June 1997
...Except for large containers, a random sample should be collected from an unopened.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....The nature and extent of end product testing beyond potency should be determined by the..
http://www.fda.gov/cder/hdn/cnotes67.htm (score=60)

PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Critical activities in the production and testing of a PET drug product that expose the PET drug product or the sterile surface.....Container assemblies should be prepared at the beginning of the day before other daily.....A batch of a PET drug product is a predefined quantity of the drug that has been produced to..
http://www.fda.gov/cder/guidance/4259dft.htm (score=59)

MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....elastomeric, plastic components or coatings of the container and closure system when in.....Documentation in Drug Applications for Container and Closure Systems Used for the..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=59)

Packaging
...If there is a need for interchangeability of container/closure materials for the drug product from one composition or supplier of a.....It is also possible for a component of the drug product to migrate through the walls of the.....If they do, adequate information to justify the use of the container system in combination with the drug product should be..
http://www.fda.gov/cder/guidance/package.htm (score=59)

HUMAN DRUG CGMP NOTES September 1996
...What types of failures must a batch of new drug product exhibit to trigger a field alert report.....A bottle cap is part of the immediate container closure system, but is not the immediate.....What types of failures must a batch of new drug product exhibit to trigger a field alert report..
http://www.fda.gov/cder/hdn/hdn996.htm (score=57)

HUMAN DRUG CGMP NOTES December 1997
...Equipment surfaces which contact sterilized drug product or sterilized container/closure surfaces should, of course.....If a USP drug product meets USP specifications, but fails a firm's internal, more stringent.....Once a container closure system has been validated, the sterility characteristic of a drug..
http://www.fda.gov/cder/hdn/cnotesd7.htm (score=57)

Applications for Parenteral Products Packaged in Plastic Immed
...parenteral drug product packaged in a plastic immediate container is a new drug under..section.....An application for approval of a parenteral product in a plastic immediate..container for which the container requires.....This MAPP describes the types of new drug application that will satisfy the..requirements..
http://www.fda.gov/cder/mapp/6020-2.pdf (score=53)

Guidanc for Industry: Container and Closure Integrity Testing in Lieu of...
...than sterility testing to confirm container and closure integrity as a part of stability.....product varies with time under the influence of a variety of environmental factors such as.....microbial barrier, and, hence, the sterility of a drug product throughout its shelf..life..
http://www.fda.gov/cber/gdlns/contain.pdf (score=76)

Earth & Plant, Inc.
...Labeling is not limited to the immediate product container but, as defined in Section 201.....Under Section 505 of the Act, a new drug may not be legally marketed in the United States.....Labeling for your firm’s product Hydroxygen Plus indicates serious violations of the..
http://www.fda.gov/foi/warning_letters/g3456d.htm (score=68)

stability guidance -draft
...If testing of the drug product in the immediate container or as marketed is needed, the samples.....Stability data should be developed for the drug product in each type of immediate container and.....this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=65)

Microsoft Word - 5320.1.doc
...Description of the Composition of the Drug Product..Description of the drug product composition.....Container Closure System..Description of the container-closure system used for the drug.....References to the corresponding drug product..sections of the CTD-Q and a reference to the ICH..
http://www.fda.gov/cder/mapp/5320.1.pdf (score=64)

Microsoft Word - 5020.1.doc
...Description of the Composition of the Drug Product..Description of the drug product composition.....Container Closure System..Description of the container-closure system used for the drug.....References to the corresponding drug product..sections of the CTD-Q and a reference to the ICH..
http://www.fda.gov/cder/mapp/5020.1.pdf (score=63)

Las Vegas Injury Lawyer